Logo-bi
Editorial
Abolfazl Barzegari, Graciela Pavon-Djavid*
Bioimpacts. 2014;4(3): 111-112. doi: 10.15171/bi.2014.002
PMCID: PMC4204034     PMID: 25337462     Scopus ID: 84908154738    
PDF
XML
Cited By:
Original Research
Sepideh Zununi Vahed, Abolfazl Barzegari, Yalda Rahbar Saadat, Somayeh Mohammadi, Nasser Samadi*
Bioimpacts. 2016;6(1): 25-31. doi: 10.15171/bi.2016.04
PMCID: PMC4916548     PMID: 27340621     Scopus ID: 84977117513    
Original Research
Sepideh Zununi Vahed, Mohammadreza Nakhjavani, Jalal Etemadi, Henghame Jamshidi, Nima Jadidian, Tala Pourlak, Sima Abediazar*
Bioimpacts. 2018;8(3): 177-183. doi: 10.15171/bi.2018.20
PMCID: PMC6128973     PMID: 30211077     Scopus ID: 85050672483    
Original Research
Sanaz Javanmardi ORCID, Samira Sadat Abolmaali* ORCID, Mohammad Javad Mehrabanpour, Mahmoud Reza Aghamaali, Ali Mohammad Tamaddon
BioImpacts. 2022;12(5): 449-461. doi: 10.34172/bi.2022.23263
PMCID: PMC9596881     PMID: 36381633     Scopus ID: 85135691124    
miR-21 overexpression can result in down-regulation of the critical inhibitory proteins in tumor cells. Anti-miR-21 delivery to resistant ovary tumor cells using the carboxymethylated PEG5k-polyethylenemine nanohydrogels bearing redox-sensitive crosslinks, knockdown the tumor associated angiogenesis and provoke apoptosis though ROS generation.
Original Article
Sheyda Jodeiry Zaer ORCID, Mahmoudreza Aghamaali*, Mohammad Amini, Mohammad Amin Doustvandi, Seyed Samad Hosseini ORCID, Behzad Baradaran, Souzan Najafi, Yalda Baghay Esfandyari, Ahad Mokhtarzadeh* ORCID
Bioimpacts. 2024;14(3): 29913. doi: 10.34172/bi.2023.29913
PMCID: PMC11199930     PMID: 38938754     Scopus ID: 85179088775    
PDF
XML
Cited By:


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge